• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Brooklyn Health Secures $6.5M to Expand AI-Powered Precision for Clinical Trial Endpoints

by Fred Pennic 05/27/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Brooklyn Health Secures $6.5M to Expand AI-Powered Precision for Clinical Trial Endpoints

What You Should Know: 

– Brooklyn Health, a neuroscience technology company focused on objective measurement of mental health announced it has secured $6.5M in seed funding led by HealthX, with participation from Metrodora Ventures, Story Ventures, RiverPark Ventures, Laconia Capital, Everywhere Ventures, Hypothesis Studio, Blue Falcon Capital, and others.

– The funding coincides with the company’s debut of its new electronic clinical outcome assessment (eCOA) solution, Willis. Willis is a comprehensive measurement platform that automates legacy services through artificial intelligence (AI), aiming to ease access to critical tools necessary for successful drug development in Central Nervous System (CNS) clinical trials.

Tackling the Measurement Crisis in Neurology and Psychiatry

Clinical trials for CNS conditions traditionally rely on clinical interviews as the primary outcome measure for treatment efficacy. These interviews allow for the scoring of symptoms through observation and are vital for measuring changes in response to treatment. However, this method faces significant challenges: clinical interviews are difficult to standardize, and scoring is often subjective and susceptible to biases. This can lead to unreliable outcome measures and is associated with placebo response, both of which are major contributors to the high failure rate of CNS clinical trials, costing the industry billions of dollars annually.

“Measurement is a core issue in neurology and psychiatry,” said Dr. Anzar Abbas, neuroscientist, CEO and founder of Brooklyn Health. “Clinical interviews, the standard for symptom assessment, are fundamentally unreliable and imprecise. Our mission at Brooklyn Health is to solve this measurement problem through accurate, sensitive and objective measures of mental health, lowering the barrier for drug discovery and enabling precision care”.

Willis: AI-Powered Precision for Clinical Trial Endpoints

Brooklyn Health’s Willis platform directly addresses these challenges through AI-powered review of clinical interview quality and score accuracy. This gives clinicians real-time feedback on interview administration and provides pharmaceutical sponsors with unprecedented visibility into data quality at scale. Prior to Willis, such interview review was an entirely manual process, making it impractical and prohibitively expensive for most study sponsors.

Willis also represents a significant modernization of the eCOA platform itself. It features an intuitive user experience, native clinician training, real-time flagging of concerning events, powerful data analytics, and streamlined communication channels between clinical sites and pharmaceutical sponsors, all built on a secure and scalable cloud architecture.

Open-Source Foundation: The Role of OpenWillis

Central to Brooklyn Health’s innovative approach is OpenWillis, an open-source Python library for digital phenotyping, which serves as the foundation of its measurement technology. Unlike competitors that often rely on proprietary algorithms, Brooklyn Health has made its core methods available to the scientific community. OpenWillis provides researchers with a simple toolkit for quantifying facial emotions, voice and speech characteristics, motor functioning, and other behavioral indicators of mental health. This bridges the gap between academic research and clinical applications, fostering a community-driven approach to the validation of novel methods in digital phenotyping.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Artificial Intelligence

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance

Most-Read

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

CB Insights’ 2026 Digital Health 50 Reveals How Agentic AI Is Becoming the Clinical Provider and Medication Access Engine

Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

M&A: Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

CVS Rebrands Health Services Segment, Launches Model for Retail Pharmacy Reimbursement

CVS Health Formalizes Tax-Free Split-Off to Carve Out CVS Pharmacy by 2028

SAMHSA and ONC Invest $20M in Behavioral Health IT Initiative

ONC Finalizes HTI-5 Deregulatory Rule to Cut $1.55B in Health IT Compliance and Accelerate FHIR APIs

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |